| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Corvus Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary | 1 | Reuters | ||
| Mo | Corvus Pharmaceuticals GAAP EPS of -$0.12 beats by $0.01 | 1 | Seeking Alpha | ||
| Mo | Corvus Pharmaceuticals, Inc.: Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results | 1 | GlobeNewswire (USA) | ||
| Fr | Corvus Pharmaceuticals Q1 2024 Earnings Preview | 1 | Seeking Alpha | ||
| Fr | New methanol-ready subsea construction vessel to sport Corvus' energy storage system | 1 | Offshore Energy Today | ||
| Do | Corvus Pharmaceuticals, Inc.: Corvus Pharmaceuticals Announces Pricing of $30.6 Million Registered Direct Offering | 3 | GlobeNewswire (USA) | ||
| Mi | Corvus Pharmaceuticals, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Mi | Corvus Energy to supply ESS for the first Net Zero Subsea Construction Vessel | 1 | PortNews | ||
| Mi | Corvus Energy to Supply ESS for First Net Zero Subsea Construction Vessel | 1 | MarineLink | ||
| 30.04. | Q1 2024 sets record for most ransomware attacks in a first quarter: Corvus | 1 | Reinsurance News | ||
| 09.04. | Corvus Pharmaceuticals, Inc.: Corvus Pharmaceuticals Announces Initiation of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis | 74 | GlobeNewswire (Europe) | Atopic dermatitis is the first immune disease indication being studied in the clinic for soquelitinib, the Company's selective ITK inhibitor Corvus anticipates releasing initial clinical data from... ► Artikel lesen | |
| 04.04. | ClassNK issues type approval certificate for lithium-ion storage battery system developed by Corvus Energy | 1 | PortNews | ||
| 04.04. | ClassNK Hands Out Type Approval Certificate for Corvus Energy's Ship Battery System | 1 | MarineLink | ||
| 04.04. | Corvus Energy's marine energy storage system wins ClassNK's nod | 1 | Offshore Energy Today | ||
| 28.03. | Corvus Insurance launches enhanced policy renewal process | - | Insurance Business America | ||
| 27.03. | Corvus streamlines cyber renewals with latest update | 1 | Reinsurance News | ||
| 20.03. | Earnings call: Corvus Pharmaceuticals outlines trials and financials | 2 | Investing.com | ||
| 19.03. | Corvus Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary | 3 | Reuters | ||
| 19.03. | Corvus Pharmaceuticals GAAP EPS of -$0.14 misses by $0.01 | 2 | Seeking Alpha | ||
| 19.03. | Corvus Pharmaceuticals, Inc.: Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results | 135 | GlobeNewswire (Europe) | Soquelitinib advancing towards initial enrollment for registrational Phase 3 clinical trial for PTCL and randomized Phase 1 clinical trial for atopic dermatitis Orphan drug designation and new interim... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 2.690 |
| NEL | 1.782 |
| PALANTIR TECHNOLOGIES | 1.689 |
| NVIDIA | 1.426 |
| TUI | 1.374 |
| BAYER | 1.366 |
| BIONTECH | 1.336 |
| SUPER MICRO COMPUTER | 1.167 |
| BYD | 1.044 |
| MERCEDES-BENZ | 1.037 |
| DEUTSCHE BANK | 1.034 |
| RHEINMETALL | 941 |
| PLUG POWER | 914 |
| RWE | 839 |
| TESLA | 836 |
| AIXTRON SE | 738 |
| DEUTSCHE LUFTHANSA | 694 |
| SIEMENS ENERGY | 684 |
| COMMERZBANK | 682 |
| VARTA | 681 |
| BASF | 668 |
| RENK GROUP | 667 |
| VOLKSWAGEN | 657 |
| ALLIANZ | 646 |
| THYSSENKRUPP | 590 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
